After recently obtaining the ISO 13485 certification for its quality system management system for medical devices, HAPPYneuron is proud to announce its partnership with the renowned pharma lab Merck KGaA. HAPPYneuron grants an exclusive license on a cognitive training program for people living with Multiple Sclerosis (MS). This Class 1 medical device is available in Merck’s « MSDialog » platform when deemed beneficial for a patient by his/her healthcare provider.
For Merck KGaA : “The HAPPYneuron software-based cognitive training is backed by more than 10 years of clinical data and is designed to address cognitive function across various domains. HAPPYneuron’s suite of cognitive training games are designed to address the cognition challenges that people living with MS face, and the games automatically adjust skill to match the need of the individual — making the platform interesting for the patient and simple for healthcare professionals to use with their patients.” To access Merck’s press release.
HAPPYneuron is proud to contribute to this project designed to help people living with MS and confirms its expertise in cognitive remediation. Franck Tarpin-Bernard, HAPPYneuron President, says “This agreement is a strong acknowledgement of the hard work we have achieved these past years to build training programs adapted to the uniqueness of each medical condition. It reinforces our willingness to become a world leader of digital cognitive remediation.”
About Merck KGaA
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.